Release of MICB Molecules by Tumor Cells: Mechanism and Soluble MICB in Sera of Cancer Patients

This publication has 30 references indexed in Scilit:

• Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
  Blood, 2005
• A Direct Role for NKG2D/MICA Interaction in Villous Atrophy during Celiac Disease
  Immunity, 2004
• Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
  Blood, 2003
• Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein
  European Journal of Immunology, 2002
• Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
  Nature, 2002
• The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing
  Immunity, 2002
• Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
  International Journal of Cancer, 2002
• Regulation of Cutaneous Malignancy by γδ T Cells
  Science, 2001
• ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor
  Published by Elsevier ,2001
• Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
  Science, 1999